Biocon Limited has informed the Exchange regarding a press release dated July 28, 2025, titled "Biocon Foundation and IISc Commemorate World Head & Neck Cancer Day".
Press Release Jul 28 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Biocon
- Press Release Jul 23 2025
- Press Release Jul 16 2025
- Biocon Biologics Expands Diabetes Portfolio with FDA Approval of Kirsty™, the First and Only Interchangeable Rapid-Acting Insulin Aspart in the United States
- Press Release Jul 07 2025
- Press Release Jul 03 2025
Later from Biocon
- Press Release Aug 07 2025
- Biocon Inaugurates First U.S. Manufacturing Facility in Cranbury, New Jersey
- Press Release Sep 11 2025
- Press Release Sep 12 2025
- Biocon Biologics Receives U.S. Food and Drug Administration Approval for Bosaya™ and Aukelso™, Denosumab Biosimilars
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon